- Report
- April 2023
- 80 Pages
Asia Pacific
From €4302EUR$4,750USD£3,712GBP
- Report
- January 2025
- 210 Pages
Global
From €4524EUR$4,995USD£3,903GBP
- Report
- April 2026
- 282 Pages
Canada
From €4393EUR$4,850USD£3,790GBP
- Report
- April 2026
- 168 Pages
India
From €4393EUR$4,850USD£3,790GBP
- Report
- April 2026
- 327 Pages
China
From €4393EUR$4,850USD£3,790GBP
- Report
- April 2026
- 372 Pages
Germany
From €4393EUR$4,850USD£3,790GBP
- Report
- May 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- May 2025
- 93 Pages
Global
From €3500EUR$4,139USD£3,125GBP
- Report
- August 2023
- 85 Pages
United States
From €4393EUR$4,850USD£3,790GBP
- Report
- May 2021
- 50 Pages
China
From €2355EUR$2,600USD£2,032GBP
- Report
- October 2024
- 98 Pages
Global
From €3500EUR$4,139USD£3,125GBP
- Report
- October 2024
- 74 Pages
Global
From €3500EUR$4,139USD£3,125GBP
- Report
- June 2026
- 50 Pages
Global
From €2400EUR$2,650USD£2,071GBP

Propofol is an anesthetic drug used in the induction and maintenance of general anesthesia. It is a short-acting intravenous hypnotic agent that produces a rapid onset of sedation and amnesia. Propofol is commonly used in the operating room, intensive care unit, and emergency department. It is also used for procedural sedation and as an adjunct to regional anesthesia. Propofol is a popular anesthetic drug due to its rapid onset and short duration of action. It is also associated with fewer side effects than other anesthetic drugs.
Propofol is manufactured by several companies, including Fresenius Kabi, Hospira, Mylan, and Teva Pharmaceuticals. It is available in a variety of formulations, including emulsions, liposomes, and injectable solutions. Propofol is also available in combination with other drugs, such as midazolam and fentanyl. Show Less Read more